Global Thiabendazole Market Growth 2025-2031

Publication ID:

LPI02255164

Publication Date:

February 27, 2025

Pages:

104

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Organic Farming [2]

Agriculture [3]

Industry & Manufacturing [4]

Description:

The global Thiabendazole market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Thiabendazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Thiabendazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Thiabendazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Thiabendazole players cover Kenvos Biotech, Merial U.S., Jiangsu Noon Crop Science, CTS Group, AKITA KONNO CO., LTD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淭hiabendazole Industry Forecast鈥� looks at past sales and reviews total world Thiabendazole sales in 2024, providing a comprehensive analysis by region and market sector of projected Thiabendazole sales for 2025 through 2031. With Thiabendazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thiabendazole industry.
This Insight Report provides a comprehensive analysis of the global Thiabendazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Thiabendazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Thiabendazole market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thiabendazole and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thiabendazole.
This report presents a comprehensive overview, market shares, and growth opportunities of Thiabendazole market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Powder
Liquid
Segmentation by Application:
Preservative
Antifungal Agent
Antiparasitic Agent
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Kenvos Biotech
Merial U.S.
Jiangsu Noon Crop Science
CTS Group
AKITA KONNO CO., LTD
Shanghai Skyblue Chemical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Thiabendazole market?
What factors are driving Thiabendazole market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Thiabendazole market opportunities vary by end market size?
How does Thiabendazole break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Thiabendazole Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Thiabendazole by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Thiabendazole by Country/Region, 2020, 2024 & 2031
2.2 Thiabendazole Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.3 Thiabendazole Sales by Type
2.3.1 Global Thiabendazole Sales Market Share by Type (2020-2025)
2.3.2 Global Thiabendazole Revenue and Market Share by Type (2020-2025)
2.3.3 Global Thiabendazole Sale Price by Type (2020-2025)
2.4 Thiabendazole Segment by Application
2.4.1 Preservative
2.4.2 Antifungal Agent
2.4.3 Antiparasitic Agent
2.4.4 Other
2.5 Thiabendazole Sales by Application
2.5.1 Global Thiabendazole Sale Market Share by Application (2020-2025)
2.5.2 Global Thiabendazole Revenue and Market Share by Application (2020-2025)
2.5.3 Global Thiabendazole Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Thiabendazole Breakdown Data by Company
3.1.1 Global Thiabendazole Annual Sales by Company (2020-2025)
3.1.2 Global Thiabendazole Sales Market Share by Company (2020-2025)
3.2 Global Thiabendazole Annual Revenue by Company (2020-2025)
3.2.1 Global Thiabendazole Revenue by Company (2020-2025)
3.2.2 Global Thiabendazole Revenue Market Share by Company (2020-2025)
3.3 Global Thiabendazole Sale Price by Company
3.4 Key Manufacturers Thiabendazole Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Thiabendazole Product Location Distribution
3.4.2 Players Thiabendazole Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Thiabendazole by Geographic Region
4.1 World Historic Thiabendazole Market Size by Geographic Region (2020-2025)
4.1.1 Global Thiabendazole Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Thiabendazole Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Thiabendazole Market Size by Country/Region (2020-2025)
4.2.1 Global Thiabendazole Annual Sales by Country/Region (2020-2025)
4.2.2 Global Thiabendazole Annual Revenue by Country/Region (2020-2025)
4.3 Americas Thiabendazole Sales Growth
4.4 APAC Thiabendazole Sales Growth
4.5 Europe Thiabendazole Sales Growth
4.6 Middle East & Africa Thiabendazole Sales Growth
5 Americas
5.1 Americas Thiabendazole Sales by Country
5.1.1 Americas Thiabendazole Sales by Country (2020-2025)
5.1.2 Americas Thiabendazole Revenue by Country (2020-2025)
5.2 Americas Thiabendazole Sales by Type (2020-2025)
5.3 Americas Thiabendazole Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Thiabendazole Sales by Region
6.1.1 APAC Thiabendazole Sales by Region (2020-2025)
6.1.2 APAC Thiabendazole Revenue by Region (2020-2025)
6.2 APAC Thiabendazole Sales by Type (2020-2025)
6.3 APAC Thiabendazole Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Thiabendazole by Country
7.1.1 Europe Thiabendazole Sales by Country (2020-2025)
7.1.2 Europe Thiabendazole Revenue by Country (2020-2025)
7.2 Europe Thiabendazole Sales by Type (2020-2025)
7.3 Europe Thiabendazole Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Thiabendazole by Country
8.1.1 Middle East & Africa Thiabendazole Sales by Country (2020-2025)
8.1.2 Middle East & Africa Thiabendazole Revenue by Country (2020-2025)
8.2 Middle East & Africa Thiabendazole Sales by Type (2020-2025)
8.3 Middle East & Africa Thiabendazole Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Thiabendazole
10.3 Manufacturing Process Analysis of Thiabendazole
10.4 Industry Chain Structure of Thiabendazole
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Thiabendazole Distributors
11.3 Thiabendazole Customer
12 World Forecast Review for Thiabendazole by Geographic Region
12.1 Global Thiabendazole Market Size Forecast by Region
12.1.1 Global Thiabendazole Forecast by Region (2026-2031)
12.1.2 Global Thiabendazole Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Thiabendazole Forecast by Type (2026-2031)
12.7 Global Thiabendazole Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Kenvos Biotech
13.1.1 Kenvos Biotech Company Information
13.1.2 Kenvos Biotech Thiabendazole Product Portfolios and Specifications
13.1.3 Kenvos Biotech Thiabendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Kenvos Biotech Main Business Overview
13.1.5 Kenvos Biotech Latest Developments
13.2 Merial U.S.
13.2.1 Merial U.S. Company Information
13.2.2 Merial U.S. Thiabendazole Product Portfolios and Specifications
13.2.3 Merial U.S. Thiabendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merial U.S. Main Business Overview
13.2.5 Merial U.S. Latest Developments
13.3 Jiangsu Noon Crop Science
13.3.1 Jiangsu Noon Crop Science Company Information
13.3.2 Jiangsu Noon Crop Science Thiabendazole Product Portfolios and Specifications
13.3.3 Jiangsu Noon Crop Science Thiabendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Jiangsu Noon Crop Science Main Business Overview
13.3.5 Jiangsu Noon Crop Science Latest Developments
13.4 CTS Group
13.4.1 CTS Group Company Information
13.4.2 CTS Group Thiabendazole Product Portfolios and Specifications
13.4.3 CTS Group Thiabendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 CTS Group Main Business Overview
13.4.5 CTS Group Latest Developments
13.5 AKITA KONNO CO., LTD
13.5.1 AKITA KONNO CO., LTD Company Information
13.5.2 AKITA KONNO CO., LTD Thiabendazole Product Portfolios and Specifications
13.5.3 AKITA KONNO CO., LTD Thiabendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 AKITA KONNO CO., LTD Main Business Overview
13.5.5 AKITA KONNO CO., LTD Latest Developments
13.6 Shanghai Skyblue Chemical Co., Ltd.
13.6.1 Shanghai Skyblue Chemical Co., Ltd. Company Information
13.6.2 Shanghai Skyblue Chemical Co., Ltd. Thiabendazole Product Portfolios and Specifications
13.6.3 Shanghai Skyblue Chemical Co., Ltd. Thiabendazole Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai Skyblue Chemical Co., Ltd. Main Business Overview
13.6.5 Shanghai Skyblue Chemical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂